在健康和神经退行衰老中对执行功能能力的评估- 一个选择性的文献综述
Mojitola I Idowu1, Andre J Szameitat1, Andrew Parton1
1Centre for Cognitive and Clinical Neuroscience (CCN), College of Health, Medicine and Life Sciences, Division of Psychology, Department of Life Sciences, Brunel University London, Uxbridge, United Kingdom.
Frontiers in aging neuroscience
|April 10, 2024
概括
本次审查强调了对老年人和患有轻度认知障碍 (MCI) 和阿尔茨海默病 (AD) 的老年人进行标准化执行功能 (EF) 测试的需要. 它确定了敏感的EF评估工具,用于检测认知能力下降.
科学领域:
- 神经科学是一个神经科学.
- 认知心理学 认知心理学
- 老年学是一门学科.
背景情况:
- 执行功能 (EF) 对于衰老中的认知健康至关重要.
- 对于健康的老年人,轻度认知障碍 (MCI) 和阿尔茨海默病 (AD) 目前的EF评估方法存在变化.
- 缺乏标准化的协议阻碍了EF下降的一致评估.
研究的目的:
- 为了确定评估执行功能下降的最敏感的测试.
- 为不同人群 (认知健康,MCI,AD) 选择适当的EF评估提供指导.
- 审查有关EF评估工具及其有效性的文献.
主要方法:
- 在主要数据库 (PubMed/Medline,PsycINFO,Embase,Web of Science,Google Scholar) 进行系统的文献搜索 (2000-2022年).
- 专注于双重任务,抑制,转移/切换和工作记忆更新.
- 分析了任务结果和在确定EF下降的差异,跨研究和人群.
主要成果:
- 各种EF评估工具在检测与年龄有关的和神经退行性衰退方面显示出不同的灵敏度.
- 任务需求和刺激因素影响了EF评估结果.
- 结果的不一致性凸显了方法标准化的需要.
结论:
- 标准化EF测试协议对于准确评估衰老和神经退行性疾病至关重要.
- 在选择EF措施时,必须仔细考虑任务特征和人口.
- 本综述为研究和临床实践提供了敏感的EF评估的见解.
相关概念视频
01:30Cognitive Development During Adulthood
94
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
94
01:26Alzheimer's Disease: Overview
468
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
468
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
122
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
122
01:30Information Processing Approach
34
The information-processing theory of cognitive development centers on fundamental mental processes, including attention, memory, and problem-solving skills. Researchers in this field examine how cognitive abilities, such as working memory, evolve and influence children's overall development. Studies indicate that children with stronger working memory tend to excel in reading comprehension, math, and problem-solving compared to peers with less efficient memory skills. Low working memory is...
34
01:14Role of Cerebellum and Prefrontal Cortex in Memory
425
The cerebellum, while traditionally associated with motor control, also plays a crucial role in memory, particularly in procedural memory, which involves learning motor tasks that become automatic through repetition. For example, studies have shown that when the cerebellum is damaged, individuals or animals lose the ability to learn conditioned motor responses, such as the conditioned eye-blink response in classical conditioning experiments with rabbits. This study demonstrates the...
425